# WOCKPHARMA share price, delivery % and history — Wockhardt Limited

> Delivery percentage for Wockhardt Limited (WOCKPHARMA) against its own history, with 6,610 sessions of split-adjusted NSE data from 2000 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/WOCKPHARMA

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 2,116.3 INR (-3.55% on the day), 2026-09-30
- Delivery: 42.8% of volume taken to demat (20-day average 34.83%)
- Volume: 8.23L shares, turnover ₹174.3Cr
- Relative volume: 0.58× of its own 20-day average

## Technicals

- RSI(14): 50.51
- ATR(14): 92.67
- SMA 50: 2,007.25, SMA 200: 1,648.27
- 52-week range: 1,086.7 – 2,422.3 (-12.63% from the high)

## Performance

- 1 week -9.16%, 1 month 12.35%, 3 months 8.53%
- 6 months 77.92%, 1 year 43.29%

## Delivery percentage

- Latest: 42.8% (2026-09-30)
- 20-day average: 34.83%
- 1-year average: 36.81%
- Percentile against its own history: 68th
- Range: 5.97% – 100% across 1,728 sessions with a reading

Over the last 20 sessions WOCKPHARMA settled 34.8% of its traded quantity, which is ordinary for an NSE equity. That is in line with its own one-year average of 36.8%. The latest session ranks higher than 68% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 34,388.2 crore
- P/E (TTM): 83.06 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 25.48 INR, split-adjusted to match the price series
- Revenue growth: 25.88% YoY, -3.73% QoQ
- Profit growth: — YoY, -34.76% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 10.99% | — |
| 3y | 9.7% | — |
| 4y | 4.7% | — |
| 5y | 3.72% | — |
| 6y | 3.16% | -9.49% |
| 7y | -1.68% | — |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 809 | 827 | -9 | -16 | -1.47 | -1.98% |
| 2024-12-31 | 721 | 708 | 21 | 20 | 0.91 | 2.77% |
| 2025-03-31 | 743 | 780 | -22 | -45 | -1.57 | -6.06% |
| 2025-06-30 | 738 | 770 | -109 | -108 | -5.53 | -14.63% |
| 2025-09-30 | 782 | 712 | 91 | 82 | 4.81 | 10.49% |
| 2025-12-31 | 888 | 836 | 67 | 61 | 3.61 | 6.87% |
| 2026-03-31 | 965 | 843 | 189 | 164 | 10.23 | 16.99% |
| 2026-06-30 | 929 | 844 | 116 | 107 | 6.55 | 11.52% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 49.08%
- Public: 50.92%
- FII: 7.22%, DII: 9.24%
- Promoter shares pledged: 14.68%

## Recent filings

- 2026-08-10: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_184569_10082026172827_iXBRL_WEB.html
- 2026-07-21: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1704130_29072026052023_WEB.xml
- 2026-05-04: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_155461_04052026190012_iXBRL_WEB.html
- 2026-04-20: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1654851_20042026030330_WEB.xml
- 2026-02-10: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_141510_10022026150820_iXBRL_WEB.html
- 2026-01-19: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1634684_11032026053902_WEB.xml
- 2025-11-03: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_124145_03112025165926_iXBRL_WEB.html
- 2025-10-17: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1551078_17102025104631_WEB.xml

Dated by the day the company broadcast the filing. 124 events are indexed for this instrument.

## About the instrument

- Listed: 2000-02-23 — latest session 2026-09-30 (6,610 sessions)
- ISIN: INE049B01025
- Series: EQ
- Liquidity rank: #80 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)
- [CIPLA](https://patternsradar.com/s/CIPLA.md) — Cipla Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/WOCKPHARMA.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.